Neutra Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Sydney Jim
- Full Time Employees
- 15
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 54 Sugar Creek Center Boulevard Houston TX United States of America 77478
- IPO Date
- Oct 12, 2011
- CIK
- 0001512886
- Website
- neutrainc.com
- Similar Companies
- Business
- Neutra Corp. (OTC: NTRR) operates as a life sciences and healthcare technology company focused on advancing clinical research and site management organization (SMO) services; it provides innovative solutions in nutraceuticals, hemp-derived wellness products including CBD tinctures, clinical-grade topicals, Delta-8 vape kits, THC-O and HHC cartridges, and CBDa/CBGa gummies through subsidiaries such as Neutra Life Sciences, Deity Wellness, and VIVIS; the company also engages in cultivation, manufacturing, formulation, distribution, and retail sales across the seed-to-sale value chain for modern healthy living solutions targeting consumers, healthcare providers, and pharmaceutical firms in multiple therapeutic areas. Founded in 2011 by Sarah Keck and headquartered in Houston, Texas with operations expanding nationwide from bases in Las Vegas, Nevada, Neutra Corp. maintains a diversified portfolio emphasizing environmental purification, food and drug innovations, and clinical trial management for top-tier pharmaceutical companies. In recent developments, the company launched Neutra Life Sciences as a wholly owned SMO subsidiary achieving positive operational cash flow in Q1 2025 following a 2024 pilot program; it reports entry into due diligence for the potential acquisition of Curaconnector.com to enhance operations; executed a binding letter of intent in 2023 to acquire Mercury Clinical Research with renewed plans after resolving internal debt issues; introduced premium vape products available at over 150 retailers in 17 states; upgraded e-commerce platforms for Deity Wellness and VIVIS; and initiated a corporate rebranding with a new logo and website to strengthen its life sciences focus.
Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth
Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth
Neutra Corp's Subsidiary Neutra Life Sciences Executes New Women's Health Joint Venture and Expands Trial Portfolio
Neutra Reflects on 2023 and Looks Forward to 2024
Neutra Announces Strategic and Financial Value Creation Plan
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
Neutra Corp. Provides Strategic Update
VIVIS-Brand CBD Products Will Be Available at Festival Foods Flagship Store
VIVIS-Brand CBD Products Will Soon Be Available at Mid-West Grocery Chain Flagship Store
Neutra On To The Next Step With Mexican Distributor
Neutra to Target Baby Boomers in Home Health and Hospice Care Bid
VIVIS CBD Gets First-Round Approval Enroute to Becoming Big Box Store Vendor
Pasadena Pharmacy Becomes the Latest Retailer to Offer VIVIS CBD Products
Houston-Area Wellness Center Nearly Sells Out of VIVIS Products During Launch Party
Neutra Now on Zoovu Platform, Giving VIVIS New Way to Reach Potential CBD Customers
Neutra Nears Major International Agreement with Mexican Distributor for VIVIS CBD Manufactured Products
Neutra Sales Skyrocket to New Highs as Big Box Store Negotiations Continue
Neutra Subsidiary Starts Process to Sell VIVIS Products at Two Big Box Retailers
Neutra Expects CBD Market to Grow as More States Open Their Economies From COVID Lockdowns